← Back to Companies

Charles River Laboratories International, Inc.

About

Charles River Laboratories International, Inc., headquartered in Wilmington, MA, provides research models and preclinical, clinical, and support services to companies worldwide. The company partners with leading pharmaceutical, biotechnology, government, and academic organizations throughout the world to provide products and services that span all stages of drug discovery and development.
(781) 222-6000
Wilmington, MA USA
11-50
www.criver.com
Primary Address:
251 Ballardvale Street
Wilmington, MA 01887-1000
USA
Parent Company:
Charles River Laboratories International, Inc.

Employees (16)

NameTitleEmailPhone NumberSocial Media
B*** B****Executive Vice President & Chief Commercial Officerb****[email protected](781) 222-****
(781) 222-****
J** F*****Chief Executive Officer
B***** G*******Corporate Executive Vice President - Discovery, Safety Assessment, Biologics & Avian Servicesb*************[email protected]
D**** H*******Senior Director, Marketing Operations, Branding & Digital Strategyd************[email protected]
A**** J******Manager, Client Services Operations & Digital Leada******[email protected]
K**** J******Associate Director, Safety Assessment Marketingk**************[email protected]
M***** K*********Senior Marketing Managerm***************[email protected]
G*** M******Senior Vice President & Chief Marketing Officerg******[email protected]
A** M*****Director, Business Developmenta********[email protected]
J******** M****Business Specialistj****[email protected]
J**** L******Corporate Vice President, Global Client Relationsj******[email protected]
A***** L**********Marketing Specialista****************[email protected]
C****** M*******Senior Marketing Automation Specialistc*******[email protected]
A***** S****Marketing Coordinatora****[email protected]
T*** S******Corporate Vice President - Investor Relationst**********[email protected]
C******* T****Senior Strategic Marketing Specialistc************[email protected]
Last Updated on Jan 30, 2020